After Zantac was pulled from the shelves, law firms have been working to get compensation for the people and families affected by the negative side effects of the medicine.
Kelley & Ferraro Associate Brian Kelley joined the America’s Work Force Union Podcast to discuss what the firm is doing for their clients with regards to both the Zantac and Roundup weed killer cases.
Zantac was pulled off the shelves in 2019 after being linked to several types of cancers. While the medication was pulled, Kelley said it was known to be potentially dangerous. However, the medication was so common, nobody gave it much thought.
According to Kelley, the case is similar to class action suit, but it is instead considered multidistrict litigation. This was the best option for the suit since everyone develops cancer at different times and at a different rate. The case is also open to families who lost someone to cancer potentially caused by Zantac.
The case is being done on a contingency basis, meaning that if the client doesn’t get paid, the firm doesn’t get paid.
Now in the discovery phase, the case has climbed to over 100,000 people. Kelley said they are currently questioning the drug maker, those who marketed it, doctors who suggested it and anyone else involved.
Roundup weed killer
Kelley said the Roundup weed killer case been ongoing for quite a while. To give an update he said a tentative settlement was reached. However, he suggested those affected still call Kelley & Ferraro, as they could be eligible for compensation.
Those affected by RoundUp were diagnosed with Non-Hodgkin’s lymphoma.